Human Papillomavirus Infections Pipeline H1 2015 Insights and Global Clinical Trials Review Reports

DALLAS, April 21, 2015 /PRNewswire/ --

LifeScienceIndustryResearch.com adds Human Papillomavirus Infections - Pipeline Review, H1 2015 and offers Human Papillomavirus Infections Global Clinical Trials Review, H2, 2014 market research reports to the pharmaceuticals and healthcare category of its research library.

The Human Papillomavirus Infections - Pipeline Review, H1 2015 report provides comprehensive information on the therapeutic development for Human Papillomavirus Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Human Papillomavirus Infections and special features on late-stage and discontinued projects. Complete research is available at http://www.lifescienceindustryresearch.com/human-papillomavirus-infections-pipeline-review-h1-2015.html .

The H1 2015 report on Human Papillomavirus Infections Pipeline is built using data and information sourced from a proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by an expert team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Companies Involved in Human Papillomavirus Infections Therapeutics Development and mentioned in this research include 3M Drug Delivery Systems, Admedus Ltd, Agilvax, Inc., Anaconda Pharma, Beijing Minhai Biotechnology Co., Ltd, Bharat Biotech International Limited, Biogenomics Limited, BioMAS Ltd., Chong Kun Dang Pharmaceutical Corp., Chongqing Zhifei Biological Products Co., Ltd., Crucell N.V., Cutanea Life Sciences, EpiPharm AG, FluGen, Inc., Foamix Pharmaceuticals Ltd., G&E Herbal Biotechnology Co., Ltd., Genticel S.A., Helix BioPharma Corp., Immunservice GmbH, Indian Immunologicals Limited, LEO Pharma A/S, MediGene AG, NanoViricides, Inc., Nielsen Biosciences, Inc. , Novan, Inc., Shanghai Zerun Biotechnology Co., Ltd., Spider Biotech, Starpharma Holdings Limited , Takeda Pharmaceutical Company Limited, Vaxart, Inc. and ViroStatics. Order a copy of this research report at http://www.lifescienceindustryresearch.com/purchase?rname=39448 .

Along with data tables, following figures have been provided in this research:

Number of Products under Development for Human Papillomavirus Infections, H1 2015

Number of Products under Development for Human Papillomavirus Infections - Comparative Analysis, H1 2015

Number of Products under Development by Companies, H1 2015

Number of Products under Investigation by Universities/Institutes, H1 2015

Comparative Analysis by Clinical Stage Development, H1 2015

Comparative Analysis by Early Stage Products, H1 2015

Assessment by Monotherapy Products, H1 2015

Number of Products by Top 10 Targets, H1 2015

Number of Products by Stage and Top 10 Targets, H1 2015

Number of Products by Top 10 Mechanism of Actions, H1 2015

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015

Number of Products by Top 10 Routes of Administration, H1 2015

Number of Products by Stage and Top 10 Routes of Administration, H1 2015

Number of Products by Top 10 Molecule Types, H1 2015

Number of Products by Stage and Top 10 Molecule Types, H1 2015

Another research on Human Papillomavirus Infections Global Clinical Trials Review, H2, 2014 provides elemental information and data relating to the clinical trials on Human Papillomavirus Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Human Papillomavirus Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope: Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each: Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type AND Listings of discontinued trials (suspended, withdrawn and terminated).

Companies and institutions like Merck & Co., GlaxoSmithKline plc, Medicis Pharmaceutical Corporation, BioMAS Ltd., AstraZeneca PLC, Novartis AG, MediGene AG, Meda AB, Genticel S.A., G&E Herbal Biotechnology Co., Ltd., The National Institute of Allergy and Infectious Diseases, National Cancer Institute, Johns Hopkins University, University of Pittsburgh, The University of Hong Kong, Leiden University Medical Center, Medical University of Vienna, AIDS Malignancy Clinical Trials Consortium, The Alfred Hospital and The University of Sydney are discussed in this research on Global Human Papillomavirus Infections Clinical Trials Review available for purchase at http://www.lifescienceindustryresearch.com/purchase?rname=29641 .

Explore more reports on pharmaceuticals industry and overall healthcare market at http://www.lifescienceindustryresearch.com/category/healthcare .

About Us:
Life Science Industry Research brings to you to the latest reports in market research on Biotechnology, Diagnostics, Healthcare, Medical Devices and Pharmaceuticals segments from leading research publishers across the globe. These reports also cover data and information on sub-segments and sectors under these life sciences categories.

Contact:
Ritesh Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel:  +1-888-391-5441
sales@lifescienceindustryresearch.com

Connect with Us: 

G+ / Google Plus: https://plus.google.com/112612135957880308475/about

Twitter: https://twitter.com/LifeSciReports

RSS / Feeds: http://www.lifescienceindustryresearch.com/feed

News: http://www.lifescienceindustryresearch.com/lifescience-news